605266 Stock Overview
Jianzhijia Pharmaceutical Chain Group Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.08 |
| 52 Week High | CN¥52.81 |
| 52 Week Low | CN¥17.18 |
| Beta | 0.86 |
| 1 Month Change | -1.06% |
| 3 Month Change | 41.82% |
| 1 Year Change | -46.47% |
| 3 Year Change | -26.85% |
| 5 Year Change | n/a |
| Change since IPO | -34.49% |
Recent News & Updates
Recent updates
Further Upside For Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Could Introduce Price Risks After 33% Bounce
Nov 12
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt
Oct 03What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?
Jul 16Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%
Jun 19Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet
Feb 27Shareholder Returns
| 605266 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | -2.4% | 0.4% | -2.7% |
| 1Y | -46.5% | 7.3% | 11.8% |
Return vs Industry: 605266 underperformed the CN Consumer Retailing industry which returned 7.3% over the past year.
Return vs Market: 605266 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 605266 volatility | |
|---|---|
| 605266 Average Weekly Movement | 9.5% |
| Consumer Retailing Industry Average Movement | 8.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 605266 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 605266's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 21,000 | Bo Lan | www.jzj.cn |
Jianzhijia Pharmaceutical Chain Group Co., Ltd. engages in the pharmaceutical retail business in China. The company operates direct operated stores, as well as an online pharmacy business.
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Fundamentals Summary
| 605266 fundamental statistics | |
|---|---|
| Market cap | CN¥4.09b |
| Earnings (TTM) | CN¥236.80m |
| Revenue (TTM) | CN¥9.32b |
17.3x
P/E Ratio0.4x
P/S RatioIs 605266 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605266 income statement (TTM) | |
|---|---|
| Revenue | CN¥9.32b |
| Cost of Revenue | CN¥5.97b |
| Gross Profit | CN¥3.34b |
| Other Expenses | CN¥3.10b |
| Earnings | CN¥236.80m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.51 |
| Gross Margin | 35.87% |
| Net Profit Margin | 2.54% |
| Debt/Equity Ratio | 118.0% |
How did 605266 perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield70%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 18:54 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jianzhijia Pharmaceutical Chain Group Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hao Wu | Chasing Securities |
| Hui Liu | China Galaxy Securities Co., Ltd. |
| Kehan Meng | Haitong International Research Limited |